Aktiesnakken — Februar 2011
-
Hovedsageligt eget direkt salg
-
Det er ret spændende for os +30'ere
-
Glæd jer til webcast og lær en del om fertilitet
-
De kan lave billigere babyer!
-
Bedre færre embryos og bedre betaling
-
Gennemsnitlig vækst cagr 35%
-
positiv cashflow
-
15% ebitda
-
Stram præsentation. Heads up. Interessant case
-
Gross margin 80%
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind